Phio Pharmaceuticals Competitors and Similar CompaniesClear all
Phio Pharmaceuticals's competitors and similar companies include Biogen, Genentech and Cipla.
 Phio Pharmaceuticals Phio Pharmaceuticals (formerly RXi Pharmaceuticals) develops therapeutics based on ribonucleic acid interference. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | |
Founding Date | Founding Date 2011 | Founding Date 1978 | Founding Date 1976 | Founding Date 1935 |
Type | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Marlborough, US HQ | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more |
Employees | Employees 940% decrease | Employees 7,605 | Employees 18,077 | Employees 27,764 |
Valuation ($) | Valuation ($) 2.8 m | Valuation ($) 26.7 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹277.1b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A | Cost of goods ₹95.5b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit $7.5b (FY, 2025) | Gross profit N/A | Gross profit ₹195b (FY, 2026) |
Net income | Net income ($8.7m) (FY, 2025) | Net income $1.3b (FY, 2025) | Net income N/A | Net income ₹38.7b (FY, 2026) |
Operating ⚠ | ||||
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 4 (FY, 2024) | Phase I Trials Products 28 (Jul, 2025) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 6 (FY, 2024) | Phase II Trials Products 19 (Jul, 2025) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2024) | Phase III Trials Products 41 (Jul, 2025) | Phase III Trials Products N/A |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View company